• Lipid-lowering agents, also sometimes referred to as hypolipidemic agents, cholesterol-lowering drugs, or antihyperlipidemic agents are a diverse group...
    12 KB (1,422 words) - 21:20, 29 May 2025
  • Dyslipidemia (redirect from Lipid disorder)
    factor for cardiovascular disease, abnormal levels do not mean that lipid lowering agents need to be started. Other factors, such as comorbid conditions and...
    31 KB (3,036 words) - 19:33, 22 May 2025
  • Thumbnail for Bezafibrate
    other brand names) is a fibrate drug used as a lipid-lowering agent to treat hyperlipidaemia. It helps to lower LDL cholesterol and triglyceride in the blood...
    8 KB (728 words) - 08:11, 23 January 2025
  • contributed to 3.8 million deaths in 2021. Hypercholesterolemia Lipid-lowering agent Fatty acid ratio in food Ahrens EH Jr (July 1976). "The management...
    20 KB (2,323 words) - 03:34, 26 May 2025
  • Thumbnail for Ciprofibrate
    Ciprofibrate is a fibrate that was developed as a lipid-lowering agent. It was patented in 1972 and approved for medical use in 1985. Fischer J, Ganellin...
    2 KB (43 words) - 00:32, 24 January 2023
  • Thumbnail for Probucol
    Probucol, sold under the trade name Lorelco among others, is an lipid-lowering agent initially developed for the treatment of coronary artery disease....
    17 KB (1,702 words) - 08:29, 25 February 2025
  • Thumbnail for Amlodipine
    CYP3A5*3 genetic polymorphisms). When more than 20 mg of simvastatin, a lipid-lowering agent, are given with amlodipine, the risk of myopathy increases. The FDA...
    45 KB (4,049 words) - 19:56, 29 May 2025
  • Thumbnail for Clofibrate
    Clofibrate (trade name Atromid-S) is a lipid-lowering agent used for controlling the high cholesterol and triacylglyceride level in the blood. It belongs...
    4 KB (241 words) - 18:01, 7 September 2024
  • Thumbnail for Red yeast rice
    Terlou RJ, Yu H, Koks CH, Gerdes VE (2015). "Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is...
    25 KB (2,922 words) - 19:18, 17 May 2025
  • Thumbnail for Lomitapide
    Lomitapide (category Hypolipidemic agents)
    Juxtapid in the US and Lojuxta in the EU, is a medication used as a lipid-lowering agent for the treatment of familial hypercholesterolemia, developed by...
    8 KB (429 words) - 22:25, 17 March 2025
  • Thumbnail for Familial hypercholesterolemia
    Familial hypercholesterolemia (category Lipid metabolism disorders)
    normally treated with statins, bile acid sequestrants, or other lipid-lowering agents that lower cholesterol levels. New cases are generally offered genetic...
    50 KB (5,688 words) - 20:49, 29 May 2025
  • Thumbnail for Acipimox
    Acipimox (category Hypolipidemic agents)
    (trade name Olbetam in Europe) is a niacin derivative used as a lipid-lowering agent. It reduces triglyceride levels and increases HDL cholesterol. It...
    5 KB (358 words) - 21:19, 4 December 2022
  • Thumbnail for Hyzetimibe
    Hyzetimibe (category Hypolipidemic agents)
    enter the body from the intestinal lumen. In China, it is used as a lipid-lowering agent and it has efficacy similar to ezetimibe. Ruan Z, Jiang B, Chen J...
    5 KB (223 words) - 17:29, 23 October 2024
  • metoprolol as alternatives. Atenolol should not be used as a first-line agent in uncomplicated hypertension in patients > 60 years. Alternatives are 4th...
    67 KB (4,835 words) - 23:03, 3 May 2025
  • Policosanol: Clinical pharmacology and therapeutic significance of a new lipid-lowering agent. In: American Heart Journal, 2002, S. 356-365. – ISSN 0002-8703 (advisory)...
    7 KB (908 words) - 12:07, 23 May 2025
  • 3-propanediol and two molecules of clofibric acid which is the true lipid-lowering agent. Verma N (2016). "Introduction to Hyperlipidemia and its Treatment:...
    3 KB (118 words) - 17:47, 7 September 2024
  • Thumbnail for Policosanol
    tolerated and is effective at lowering the blood cholesterol. As of 2010, they were marketed as lipid-lowering agents in the Caribbean, Central and South...
    6 KB (527 words) - 08:33, 21 October 2023
  • Thumbnail for Atorvastatin
    who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre...
    98 KB (9,279 words) - 22:47, 30 May 2025
  • Rasburicaseα Ferrous salt Folic acid Hydroxocobalamin Erythropoiesis-stimulating agents Enoxaparin Phytomenadione Desmopressinα Heparin sodiumα Protamine sulfateα...
    38 KB (2,574 words) - 07:00, 27 May 2025
  • Thumbnail for Avasimibe
    Avasimibe (category Hypolipidemic agents)
    discovered by Parke-Davis (later Pfizer) and developed as a possible lipid-lowering agent and treatment for atherosclerosis. The first description of avasimibe...
    11 KB (1,128 words) - 15:19, 24 October 2024
  • Thumbnail for Lipid
    Lipids are a broad group of organic compounds which include fats, waxes, sterols, fat-soluble vitamins (such as vitamins A, D, E and K), monoglycerides...
    71 KB (7,372 words) - 09:57, 14 May 2025
  • Thumbnail for Triphenylethanol
    never-marketed antiestrogen ethamoxytriphetol (MER-25): 7  and the withdrawn lipid-lowering agent triparanol, as both contain the 1,1,2-triphenylethanol moiety within...
    2 KB (190 words) - 10:26, 1 March 2024
  • Albendazol-sulfoxide Anthelmintic agent Sheep/Cattle In vitro Virkel, Lifschitz, Pis, & Lanusee, 2002 Lifibrol Lipid lowering  agent Dog In vitro Walter, & Hsu...
    27 KB (3,018 words) - 08:13, 28 May 2025
  • Thumbnail for Lipid pneumonia
    Lipoid pneumonia, also known as lipid pneumonia, is a rare form of lung inflammation (pneumonia) that develops when lipids (fats) enter the bronchial tree...
    11 KB (1,087 words) - 18:00, 30 May 2025
  • Thumbnail for Efaproxiral
    Efaproxiral (INN) is an analogue of bezafibrate [a lipid-lowering agent], developed for the treatment of depression, traumatic brain injury, ischemia,...
    8 KB (680 words) - 10:44, 28 June 2024
  • Thumbnail for Lipid bilayer
    The lipid bilayer (or phospholipid bilayer) is a thin polar membrane made of two layers of lipid molecules. These membranes form a continuous barrier around...
    84 KB (10,050 words) - 15:33, 30 May 2025
  • Thumbnail for Hypercholesterolemia
    Hypercholesterolemia (category Lipid metabolism disorders)
    hypercholesterolemia), diet is often not sufficient to achieve the desired lowering of LDL, and lipid-lowering medications are usually required. If necessary, other treatments...
    61 KB (6,213 words) - 17:53, 22 May 2025
  • Thumbnail for Chandler's disease
    head. External factors that can cause these emboli can include alcohol, lipid circulation, high doses of glucocorticoids, and new increases in bone marrow...
    29 KB (3,519 words) - 17:39, 26 May 2025
  • Thumbnail for Statin
    Statin (category Anti-inflammatory agents)
    via the mechanisms described by the lipid hypothesis. As lipid-lowering medications, statins are effective in lowering LDL cholesterol; they are widely used...
    137 KB (13,369 words) - 22:14, 29 May 2025
  • Thumbnail for Rosuvastatin
    Adams SP, Sekhon SS, Wright JM (November 2014). "Rosuvastatin for lowering lipids". The Cochrane Database of Systematic Reviews. 2014 (11): CD010254...
    42 KB (3,482 words) - 22:06, 29 May 2025